BSEInsider Trading / SAST2h ago · 25 Sept 2026, 04:26 pm
Intimation of Closure of Trading Window pursuant to declaration of Unaudited Financial Results for the quarter ended September 30, 2026.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryResults
Venmax Drugs and Pharmaceuticals Ltd has announced the closure of its trading window for 48 hours after declaring unaudited financial results for the quarter ended September 30, 2026. The trading window will be closed for all insiders, including designated persons and their immediate relatives, from October 1, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading Window